Solid tumors are much more common than hematologic malignancies. Although severe and
prolonged neutropenia is uncommon, several factors increase the risk of infection in patients …

Neutropenia and febrile neutropenia (FN) are common complications of myelosuppressive
chemotherapy. This review provides an up-to-date assessment of the patient and cost …

Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression:
ASCO and IDSA Clinical Practice Guideline Up Page 1 JOURNAL OF CLINICAL …

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American
Society of Clinical Oncology and Infec Page 1 JOURNAL OF CLINICAL ONCOLOGY ASCO …

Background Emerging data suggest variability in susceptibility and outcome to coronavirus
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …

Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

abstract Bloodstream infections (BSI) are among the most frequent complications in
neutropenic cancer patients and, if caused by Gram-negative rods, are associated with high …

Febrile neutropenia remains an important complication of treatment with cytotoxic
chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this …

Objectives Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European
Conference on Infections in Leukemia (ECIL) for patients with prolonged neutropenia. In …

Background Myeloma causes profound immunodeficiency and recurrent, serious infections.
Around 5500 new cases of myeloma are diagnosed per year in the UK, and a quarter of …